NCT07003451View on ClinicalTrials.gov

Novel Biomarkers in Assessment of Interstitial Lung Disease Associated With Rheumatoid Arthritis Patients

Not yet recruitingOBSERVATIONAL
Enrollment

60

Participants

Timeline

Start Date

October 1, 2025

Primary Completion Date

January 1, 2026

Study Completion Date

June 1, 2026

Conditions
Rheumatoid ArthritisInterstitial Lung Disease
Interventions
DIAGNOSTIC_TEST

Calprotectin Level

Measurement of calprotectin level to presence and severity of ILD asessed via Warrick's score

Trial Locations (1)

71515

Assiut University hospital, Asyut

All Listed Sponsors
lead

Assiut University

OTHER

NCT07003451 - Novel Biomarkers in Assessment of Interstitial Lung Disease Associated With Rheumatoid Arthritis Patients | Biotech Hunter | Biotech Hunter